According to UNICEF's State of the World's Children 2023 report, in Latin America and the Caribbean, 6.8 million children did ...

Jazz Pharmaceuticals has reported third-quarter revenue of $1 billion, a 9% increase over the prior year, fueled by strong ...

German pharma major Bayer’s independently operated subsidiary Asklepios BioPharmaceutical (AskBio) today announced that AB-1003 (also known as LION-101) has received rare pediatric disease designation ...

The global Duchenne muscular dystrophy (DMD) therapeutics market is set to grow by $4.4 billion from 2024 to 2028, with a ...

US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the ...

BioCity Biopharma has reported positive Phase II results for SC0062 in treating IgA nephropathy, showing up to a 48.3% ...

Moderna posted Q3 2024 revenues of $1.9 billion, up from $1.8 billion in Q3 2023, with net income reaching $13 million, a turnaround from last year’s $3.6 billion loss. Growth was driven by strong US ...

US biotech major Gilead Sciences was trading nearly 2% higher in pre-market on Thursday after announcing its third-quarter ...

Maryland-based MacroGenics, a biopharma focused on discovering, developing, manufacturing and commercializing innovative ...

Oncology-focused biotech company Tango Therapeutics announced an update on its PRMT5 program. Tango noted that, based on ...

US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer ...

UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China.